PRODUCTS
SERVICES
The primary investment objective of the scheme is to seek to generate consistent returns bypredominantly investing in equity and equity related securities of pharmaceutical and healthcarecompanies.
1.98
5 yrs 4 m
0.5%
2,352.32 Crs
0.50% on or before 1M, Nil after 1M
Large Growth
6.64
SIP 100 & Lumpsum 100
S&P BSE HEALTH CARE - TRI
Chirag Dagli,Jay Kothari
Investors understand that their principal will be at very high risk